"DNA clues to malaria in ancient Rome", BBC News, February 20, 2001.
, in reference to Sallares R, Gomzi S (2001). “Biomolecular archaeology of malaria”, Ancient Biomolecules3 (3), p. 195–213.
(2005) “Is malaria a disease of poverty? A review of the literature”, Tropical Health and Medicine10 (10), p. 1047–59. doi:10.1111/j.1365-3156.2005.01476.x.
Greenwood BM, Bojang K, Whitty CJ, Targett GA (2005). “Malaria”, Lancet365 (9469), p. 1487–98. doi:10.1016/S0140-6736(05)66420-3.
Nadjm B, Behrens RH (2012). “Malaria: An update for physicians”, Infectious Disease Clinics of North America26 (2), p. 243–59. doi:10.1016/j.idc.2012.03.010.
Bartoloni A, Zammarchi L (2012). “Clinical aspects of uncomplicated and severe malaria”, Mediterranean Journal of Hematology and Infectious Diseases4 (1), p. e2012026. doi:10.4084/MJHID.2012.026.
Taylor WR, Hanson J, Turner GD, White NJ, Dondorp AM (2012). “Respiratory manifestations of malaria”, Chest142 (2), p. 492–505. doi:10.1378/chest.11-2655.
Beare NA, Lewallen S, Taylor TE, Molyneŭ ME (2011). “Redefining cerebral malaria by including malaria retinopathy”, Future Microbiology6 (3), p. 349–55. doi:10.2217/fmb.11.3.
Hartman TK, Rogerson SJ, Fischer PR (2010). “The impact of maternal malaria on newborns”, Annals of Tropical Paediatrics30 (4), p. 271–82. doi:10.1179/146532810X12858955921032.
Rijken MJ, McGready R, Boel ME, Poespoprodjo R, Singh N, Syafruddin D, Rogerson S, Nosten F (2012). “Malaria in pregnancy in the Asia-Pacific region”, Lancet Infectious Diseases12 (1), p. 75–88. doi:10.1016/S1473-3099(11)70315-2.
Mueller I, Zimmerman PA, Reeder JC (2007). “Plasmodium malariae and Plasmodium ovale—the "bashful" malaria parasites”, Trends in Parasitology23 (6), p. 278–83. doi:10.1016/j.pt.2007.04.009.
Collins WE (2012). “Plasmodium knowlesi: A malaria parasite of monkeys and humans”, Annual Review of Entomology57, p. 107–21. doi:10.1146/annurev-ento-121510-133540.
Sarkar PK, Ahluwalia G, Vijayan VK, Talwar A (2009). “Critical care aspects of malaria”, Journal of Intensive Care Medicine25 (2), p. 93–103. doi:10.1177/0885066609356052.
Baird JK (2013). “Evidence and implications of mortality associated with acute Plasmodium vivax malaria”, Clinical Microbiology Reviews26 (1), p. 36–57. doi:10.1128/CMR.00074-12.
Arnott A, Barry AE, Reeder JC (2012). “Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination”, Malaria Journal11, p. 14. doi:10.1186/1475-2875-11-14.
Collins WE, Barnwell JW (2009). “Plasmodium knowlesi: finally being recognized”, Journal of Infectious Diseases199 (8), p. 1107–8. doi:10.1086/597415.
Cowman AF, Berry D, Baum J (2012). “The cellular and molecular basis for malaria parasite invasion of the human red blood cell”, Journal of Cell Biology198 (6), p. 961–71. doi:10.1083/jcb.201206112.
Owusu-Ofori AK, Parry C, Bates I (2010). “Transfusion-transmitted malaria in countries where malaria is endemic: A review of the literature from sub-Saharan Africa”, Clinical Infectious Diseases51 (10), p. 1192–8. doi:10.1086/656806.
White NJ (2011). “Determinants of relapse periodicity in Plasmodium vivax malaria”, Malaria Journal10, p. 297. doi:10.1186/1475-2875-10-297.
Tran TM, Samal B, Kirkness E, Crompton PD (2012). “Systems immunology of human malaria”, Trends in Parasitology28 (6), p. 248–57. doi:10.1016/j.pt.2012.03.006.
Vaughan AM, Aly AS, Kappe SH (2008). “Malaria parasite pre-erythrocytic stage infection: Gliding and hiding”, Cell Host & Microbe4 (3), p. 209–18. doi:10.1016/j.chom.2008.08.010.
Richter J, Franken G, Mehlhorn H, Labisch A, Häussinger D (2010). “What is the evidence for the existence of Plasmodium ovale hypnozoites?”, Parasitology Research107 (6), p. 1285–90. doi:10.1007/s00436-010-2071-z.
Tilley L, Dixon MW, Kirk K (2011). “The Plasmodium falciparum-infected red blood cell”, International Journal of Biochemistry and Cell Biology43 (6), p. 839–42. doi:10.1016/j.biocel.2011.03.012.
Mens PF, Bojtor EC, Schallig HDFH (2012). “Molecular interactions in the placenta during malaria infection”, European Journal of Obstetrics & Gynecology and Reproductive Biology152 (2), p. 126–32. doi:10.1016/j.ejogrb.2010.05.013.
Rénia L, Wu Howland S, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, Russell B, Ng LF (2012). “Cerebral malaria: mysteries at the blood-brain barrier”, Virulence3 (2), p. 193–201. doi:10.4161/viru.19013.
Kwiatkowski DP (2005). “How malaria has affected the human genome and what human genetics can teach us about malaria”, American Journal of Human Genetics77 (2), p. 171–92. doi:10.1086/432519.
Hedrick PW (2011). “Population genetics of malaria resistance in humans”, Heredity107 (4), p. 283–304. doi:10.1038/hdy.2011.16.
Weatherall DJ (2008). “Genetic variation and susceptibility to infection: The red cell and malaria”, British Journal of Haematology141 (3), p. 276–86. doi:10.1111/j.1365-2141.2008.07085.x.
Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P (2011). “Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries”, Cochrane Database of Systematic Reviews (7), p. CD008122. doi:10.1002/14651858.CD008122.pub2.
Kattenberg JH, Ochodo EA, Boer KR, Schallig HD, Mens PF, Leeflang MM (2011). “Systematic review and meta-analysis: Rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women”, Malaria Journal10, p. 321. doi:10.1186/1475-2875-10-321.
Wilson ML (2012). “Malaria rapid diagnostic tests”, Clinical Infectious Diseases54 (11), p. 1637–41. doi:10.1093/cid/cis228.
Perkins MD, Bell DR (2008). “Working without a blindfold: The critical role of diagnostics in malaria control”, Malaria Journal1 (Suppl 1), p. S5. doi:10.1186/1475-2875-7-S1-S5.
Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG (2010). “Costs and financial feasibility of malaria elimination”, Lancet376 (9752), p. 1604–15. doi:10.1016/S0140-6736(10)61355-4.
(13a de Januaro 2015) “Intermittent preventive antimalarial treatment for children with anaemia.”, The Cochrane database of systematic reviews1, p. CD010767. doi:10.1002/14651858.CD010767.pub2.
Lengeler C (2004). “Insecticide-treated bed nets and curtains for preventing malaria”, Cochrane Database of Systematic Reviews (2), p. CD000363. doi:10.1002/14651858.CD000363.pub2.
Tanser FC, Lengeler C, Sharp BL (2010). “Indoor residual spraying for preventing malaria”, Cochrane Database of Systematic Reviews (4), p. CD006657. doi:10.1002/14651858.CD006657.pub2.
Howitt P, Darzi A, Yang GZ, Ashrafian H, Atun R, Barlow J, Blakemore A, Bull AM, Car J, Conteh L, Cooke GS, Ford N, Gregson SA, Kerr K, King D, Kulendran M, Malkin RA, Majeed A, Matlin S, Merrifield R, Penfold HA, Reid SD, Smith PC, Stevens MM, Templeton MR, Vincent C, Wilson E (2012). “Technologies for global health”, The Lancet380 (9840), p. 507–35. doi:10.1016/S0140-6736(12)61127-1.
Miller JM, Korenromp EL, Nahlen BL, W Steketee R (2007). “Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets”, Journal of the American Medical Association297 (20), p. 2241–50. doi:10.1001/jama.297.20.2241.
Noor AM, Mutheu JJ, Tatem AJ, Hay SI, Snow RW (2009). “Insecticide-treated net coverage in Africa: Mapping progress in 2000–07”, Lancet373 (9657), p. 58–67. doi:10.1016/S0140-6736(08)61596-2.
Enayati A, Hemingway J (2010). “Malaria management: Past, present, and future”, Annual Review of Entomology55, p. 569–91. doi:10.1146/annurev-ento-112408-085423.
van den Berg H (2009). “Global status of DDT and its alternatives for use in vector control to prevent disease”, Environmental Health Perspectives117 (11), p. 1656–63. doi:10.1289/ehp.0900785.
Jacquerioz FA, Croft AM (2009). “Drugs for preventing malaria in travellers”, Cochrane Database of Systematic Reviews (4), p. CD006491. doi:10.1002/14651858.CD006491.pub2.
Fernando SD, Rodrigo C, Rajapakse S (2011). “Chemoprophylaxis in malaria: Drugs, evidence of efficacy and costs”, Asian Pacific Journal of Tropical Medicine4 (4), p. 330–6. doi:10.1016/S1995-7645(11)60098-9.
(Oct 10, 2014) “Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.”, The Cochrane database of systematic reviews10, p. CD000169. doi:10.1002/14651858.CD000169.pub3.
Turschner S, Efferth T (2009). “Drug resistance in Plasmodium: Natural products in the fight against malaria”, Mini Reviews in Medicinal Chemistry9 (2), p. 206–14. doi:10.2174/138955709787316074.
Meremikwu MM, Odigwe CC, Akudo Nwagbara B, Udoh EE (2012). “Antipyretic measures for treating fever in malaria”, Cochrane Database of Systematic Reviews9, p. CD002151. doi:10.1002/14651858.CD002151.pub2.
Kokwaro G (2009). “Ongoing challenges in the management of malaria”, Malaria Journal8 (Suppl 1), p. S2. doi:10.1186/1475-2875-8-S1-S2.
Keating GM (2012). “Dihydroartemisinin/piperaquine: A review of its use in the treatment of uncomplicated Plasmodium falciparum malaria”, Drugs72 (7), p. 937–61. doi:10.2165/11203910-000000000-00000.
Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K (2011). “A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy”, Malaria Journal11, p. 141. doi:10.1186/1475-2875-11-141.
O'Brien C, Henrich PP, Passi N, Fidock DA (2011). “Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum”, Current Opinion in Infectious Diseases24 (6), p. 570–7. doi:10.1097/QCO.0b013e32834cd3ed.
Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM (2012). “Artemisinin-resistant malaria: research challenges, opportunities, and public health implications”, American Journal of Tropical Medicine and Hygiene87 (2), p. 231–41. doi:10.4269/ajtmh.2012.12-0025.
Sinclair D, Donegan S, Isba R, Lalloo DG (2012). “Artesunate versus quinine for treating severe malaria”, Cochrane Database of Systematic Reviews6, p. CD005967. doi:10.1002/14651858.CD005967.pub4.
Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L (2010). “Artemisinin resistance: Current status and scenarios for containment”, Nature Reviews Microbiology8 (4), p. 272–80. doi:10.1038/nrmicro2331.
(2014) “Spread of artemisinin resistance in Plasmodium falciparum malaria”, New England Journal of Medicine371 (5), p. 411–23. doi:10.1056/NEJMoa1314981.
Trampuz A, Jereb M, Muzlovic I, Prabhu R (2003). “Clinical review: Severe malaria”, Critical Care7 (4), p. 315–23. doi:10.1186/cc2183.
Riley EM, Stewart VA (2013). “Immune mechanisms in malaria: New insights in vaccine development”, Nature Medicine19 (2), p. 168–78. doi:10.1038/nm.3083.
Idro R, Marsh K, John CC, Newton CRJ (2010). “Cerebral malaria: Mechanisms of brain injury and strategies for improved neuro-cognitive outcome”, Pediatric Research68 (4), p. 267–74. doi:10.1203/PDR.0b013e3181eee738.
Olupot-Olupot P, Maitland, K (2013). “Management of severe malaria: Results from recent trials”, Advances in Experimental Medicine and Biology764, p. 241–50. doi:10.1007/978-1-4614-4726-9_20.
Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD (2012). “Global malaria mortality between 1980 and 2010: A systematic analysis”, Lancet379 (9814), p. 413–31. doi:10.1016/S0140-6736(12)60034-8.
(2012) “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010”, Lancet380 (9859), p. 2095–128. doi:10.1016/S0140-6736(12)61728-0.
Guerra CA, Hay SI, Lucioparedes LS, Gikandi PW, Tatem AJ, Noor AM, Snow RW (2007). “Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project”, Malaria Journal6 (1), p. 17. doi:10.1186/1475-2875-6-17.
Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW (2010). “Estimating the global clinical burden of Plasmodium falciparum malaria in 2007”, PLoS Medicine7 (6), p. e1000290. doi:10.1371/journal.pmed.1000290.
Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G (2012). “Malaria in the Greater Mekong Subregion: Heterogeneity and complexity”, Acta Tropica121 (3), p. 227–39. doi:10.1016/j.actatropica.2011.02.016.
Harper K, Armelagos G (2011). “The changing disease-scape in the third epidemiological transition”, International Journal of Environmental Research and Public Health7 (2), p. 675–97. doi:10.3390/ijerph7020675.
Prugnolle F, Durand P, Ollomo B, Duval L, Ariey F, Arnathau C, Gonzalez JP, Leroy E, Renaud F (2011). “A fresh look at the origin of Plasmodium falciparum, the most malignant malaria agent”, PLoS Pathogens7 (2), p. e1001283. doi:10.1371/journal.ppat.1001283.
Cox F (2002). “History of human parasitology”, Clinical Microbiology Reviews15 (4), p. 595–612. doi:10.1128/CMR.15.4.595-612.2002.
(1999) “From Shakespeare to Defoe: malaria in England in the Little Ice Age.”, Emerging Infectious Diseases6 (1), p. 1–11. doi:10.3201/eid0601.000101.
Kaufman TS, Rúveda EA (2005). “The quest for quinine: Those who won the battles and those who won the war”, Angewandte Chemie (International Edition in English)44 (6), p. 854–85. doi:10.1002/anie.200400663.
Kyle R, Shampe M (1974). “Discoverers of quinine”, Journal of the American Medical Association229 (4), p. 462. doi:10.1001/jama.229.4.462.
Hsu E (2006). “Reflections on the 'discovery' of the antimalarial qinghao”, British Journal of Clinical Pharmacology61 (3), p. 666–70. doi:10.1111/j.1365-2125.2006.02673.x.
Killeen G, Fillinger U, Kiche I, Gouagna L, Knols B (2002). “Eradication of Anopheles gambiae from Brazil: Lessons for malaria control in Africa?”, Lancet Infectious Diseases2 (10), p. 618–27. doi:10.1016/S1473-3099(02)00397-3.
Vanderberg JP (2009). “Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond”, Vaccine27 (1), p. 2–9. doi:10.1016/j.vaccine.2008.10.028.
(2002) “The economic and social burden of malaria”, Nature415 (6872), p. 680–5. doi:10.1038/415680a.
Ricci F (2012). “Social implications of malaria and their relationships with poverty”, Mediterranean Journal of Hematology and Infectious Diseases4 (1), p. e2012048. doi:10.4084/MJHID.2012.048.
(2006) “Counterfeit and substandard antimalarial drugs in Cambodia”, Transactions of the Royal Society of Tropical Medicine and Hygiene100 (11), p. 1019–24. doi:10.1016/j.trstmh.2006.01.003.
(2008) “A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia”, PLoS Medicine5 (2), p. e32. doi:10.1371/journal.pmed.0050032.
(2009) “Spurious and counterfeit drugs: A growing industry in the developing world”, Postgraduate Medical Journal85 (1003), p. 251–6. doi:10.1136/pgmj.2008.073213.
(2008) “Substandard medicines in resource-poor settings: A problem that can no longer be ignored”, Tropical Medicine & International Health13 (8), p. 1062–72. doi:10.1111/j.1365-3156.2008.02106.x.
(2012) “Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa”, Lancet Infectious Diseases12 (6), p. 488–96. doi:10.1016/S1473-3099(12)70064-6.
Williams LL (1963). “Malaria eradication in the United States”, American Journal of Public Health and the Nation's Health53 (1), p. 17–21. doi:10.2105/AJPH.53.1.17.
(2012) “History of malaria research and its contribution to the malaria control success in Suriname: A review”, Malaria Journal11, p. 95. doi:10.1186/1475-2875-11-95.
(2012) “Malaria control in Bhutan: Case study of a country embarking on elimination”, Malaria Journal11, p. 9. doi:10.1186/1475-2875-11-9.
(2010) “Advances and challenges in malaria vaccine development”, Journal of Clinical Investigation120 (12), p. 4168–78. doi:10.1172/JCI44423.
(2006) “Vaccines for preventing malaria (blood-stage)”, Cochrane Database of Systematic Reviews (4), p. CD006199. doi:10.1002/14651858.CD006199.
(2006) “Vaccines for preventing malaria (SPf66)”, Cochrane Database of Systematic Reviews (2), p. CD005966. doi:10.1002/14651858.CD005966.
(2010) “Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria”, Human Vaccines6 (1), p. 97–106. doi:10.4161/hv.6.1.10396.
(2010) “Malaria, Plasmodium falciparum and its apicoplast”, Biochemical Society Transactions38 (3), p. 775–82. doi:10.1042/BST0380775.
(2010) “Vitamin B metabolism in Plasmodium falciparum as a source of drug targets”, Trends in Parasitology26 (1), p. 35–43. doi:10.1016/j.pt.2009.10.006.
(2011) “Thiamin (vitamin B1) biosynthesis and regulation: A rich source of antimicrobial drug targets?”, International Journal of Biological Sciences7 (1), p. 41–52. doi:10.7150/ijbs.7.41.
(2012) “The therapeutic potential of metal-based antimalarial agents: Implications for the mechanism of action”, Dalton Transactions41 (21), p. 6335–49. doi:10.1039/C2DT12247B.
(2012) “Ferrocene-based antimalarials”, Future Medicinal Chemistry4 (6), p. 783–97. doi:10.4155/fmc.12.26.
(2002) “Anopheles gambiae genome: completing the malaria triad”, Science298 (5591), p. 13. doi:10.1126/science.298.5591.13.
(2002) “Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite”, Nature417 (6887), p. 452–5. doi:10.1038/417452a.
Baird JK. (2009). “Malaria zoonoses”, Travel Medicine and Infectious Disease7 (5), p. 269–77. doi:10.1016/j.tmaid.2009.06.004.
Ameri M (2010). “Laboratory diagnosis of malaria in nonhuman primates”, Veterinary Clinical Pathology39 (1), p. 5–19. doi:10.1111/j.1939-165X.2010.00217.x.
(2008) “Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines”, Eukaryotic Cell7 (11), p. 1875–9. doi:10.1128/EC.00242-08.
(2012) “Ecology and conservation biology of avian malaria”, Annals of the New York Academy of Sciences1249, p. 211–26. doi:10.1111/j.1749-6632.2011.06431.x.
[http://ftp.iza.org/dp2997.pdf D. Gollin D, C. Zimmermann C: Malaria - Disease Impacts and Long-Run Income Differences (angle), aŭgusto 2007, eldoninto Institute for the Study of Labor, en formato PDF
jpgmonline.com
Bhalla A, Suri V, Singh V (2006). “Malarial hepatopathy”, Journal of Postgraduate Medicine52 (4), p. 315–20.